POM POMDOCTOR Ltd

Fundamentals / CIK 0001877971 / CNY

POMDOCTOR Ltd reported ¥399.9M in revenue and a net loss of ¥212.6M for the fiscal year ended December 31, 2025 (up 16.7% year over year), with a 13.1% gross margin and a -29.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open POM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in CNY.

¥416.6M¥208.3M¥0-¥232.8MFY 2023 Revenue: ¥304.9MFY 2023 Net Income: -¥145.4M2023FY 2024 Revenue: ¥342.6MFY 2024 Net Income: -¥143.4M2024FY 2025 Revenue: ¥399.9MFY 2025 Net Income: -¥212.6M2025

Financial statements and ratios

Reported in CNY. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in CNY · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Revenue ¥399.9M ¥342.6M ¥304.9M
Cost of Revenue ¥347.6M ¥294.9M ¥266.1M
Gross Profit ¥52.28M ¥47.69M ¥38.72M
Research & Development ¥12.86M ¥3.00M ¥3.37M
Selling, General & Admin ¥155.9M ¥68.24M ¥55.99M
Total Operating Expenses ¥170.9M ¥73.49M ¥60.97M
Operating Income -¥118.6M -¥25.79M -¥22.25M
EBITDA -¥118.5M -¥25.66M -¥22.14M
Interest Expense ¥3.94M ¥3.63M ¥3.00M
Income Before Tax -¥130.9M -¥37.37M -¥36.95M
Income Tax Expense ¥375 -- --
Net Income -¥212.6M -¥143.4M -¥145.4M
Basic EPS -¥21.96 -¥22.72 -¥23.04
Diluted EPS -¥21.96 -¥22.72 -¥23.04
Basic Shares Outstanding 9.7M 6.3M 6.3M
Diluted Shares Outstanding 9.7M 6.3M 6.3M

Income Statement (Quarterly) · Reported in CNY · Newest filing period first.

No quarterly income statement rows are available in SEC EDGAR CompanyFacts for POM.

Balance Sheet (Annual) · Reported in CNY · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents ¥9.58M ¥7.65M
Cash & Short-Term Investments ¥9.58M ¥7.65M
Accounts Receivable, Net ¥18.44M ¥8.37M
Inventory ¥8.28M ¥9.17M
Other Current Assets ¥3.56M ¥2.68M
Total Current Assets ¥105.0M ¥37.50M
Property, Plant & Equipment, Net ¥1.25M ¥461K
Other Non-Current Assets ¥1.34M ¥831K
Total Non-Current Assets ¥2.59M ¥8.73M
Total Assets ¥107.6M ¥46.23M
Accounts Payable ¥44.81M ¥25.32M
Short-Term Debt ¥53.00M ¥34.96M
Other Current Liabilities -- ¥2.08M
Total Current Liabilities ¥218.2M ¥179.1M
Total Non-Current Liabilities ¥370.7M ¥366.8M
Total Liabilities ¥588.9M ¥545.9M
Total Debt (incl. Leases) ¥55.84M ¥38.02M
Retained Earnings -¥2.48B -¥2.26B
Accumulated Other Comp. Income -¥1.75M -¥5.2K
Total Stockholders' Equity -¥454.0M -¥2.26B
Total Equity -¥481.3M -¥2.26B

Balance Sheet (Quarterly) · Reported in CNY · Newest filing period first.

Balance Sheet 2025-12-31 2024-12-31
Cash & Cash Equivalents ¥9.58M ¥7.65M
Cash & Short-Term Investments ¥9.58M ¥7.65M
Accounts Receivable, Net ¥18.44M ¥8.37M
Inventory ¥8.28M ¥9.17M
Other Current Assets ¥3.56M ¥2.68M
Total Current Assets ¥105.0M ¥37.50M
Property, Plant & Equipment, Net ¥1.25M ¥461K
Other Non-Current Assets ¥1.34M ¥831K
Total Non-Current Assets ¥2.59M ¥8.73M
Total Assets ¥107.6M ¥46.23M
Accounts Payable ¥44.81M ¥25.32M
Short-Term Debt ¥53.00M ¥34.96M
Other Current Liabilities -- ¥2.08M
Total Current Liabilities ¥218.2M ¥179.1M
Total Non-Current Liabilities ¥370.7M ¥366.8M
Total Liabilities ¥588.9M ¥545.9M
Total Debt (incl. Leases) ¥55.84M ¥38.02M
Retained Earnings -¥2.48B -¥2.26B
Accumulated Other Comp. Income -¥1.75M -¥5.2K
Total Stockholders' Equity -¥454.0M -¥2.26B
Total Equity -¥481.3M -¥2.26B

Cash Flow Statement (Annual) · Reported in CNY · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -¥130.9M -¥37.37M -¥36.95M
Depreciation & Amortization ¥149K ¥135K ¥112K
Stock-Based Compensation ¥16.42M -- --
Change in Receivables -¥10.10M ¥20.31M -¥1.27M
Change in Inventory -¥998K ¥3.03M -¥5.00M
Change in Payables ¥19.49M -¥16.25M -¥1.63M
Operating Cash Flow -¥148.5M -¥16.13M -¥45.80M
Capital Expenditure -¥1.01M -¥38K -¥112K
Free Cash Flow -¥149.5M -¥16.17M -¥45.91M
Investing Cash Flow -¥1.61M -¥33K -¥112K
Financing Cash Flow ¥153.9M ¥17.02M ¥50.07M
Net Change in Cash ¥1.93M ¥847K ¥4.16M

Cash Flow Statement (Quarterly) · Reported in CNY · Newest filing period first.

No quarterly cash flow statement rows are available in SEC EDGAR CompanyFacts for POM.

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Gross Margin 13.1% 13.9% 12.7%
Operating Margin -29.7% -7.5% -7.3%
Net Profit Margin -53.2% -41.9% -47.7%
Return on Assets (ROA) -197.6% -310.1% --
Current Ratio 0.48x 0.21x --
Quick Ratio 0.44x 0.16x --
Revenue Growth (YoY) +16.7% +12.4% --
Gross Profit Growth (YoY) +9.6% +23.2% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

No quarterly ratios & growth rows are available in SEC EDGAR CompanyFacts for POM.
Source: SEC EDGAR CompanyFacts (CIK 0001877971) · from December 31, 2023 Data through December 31, 2025 · synced Nov 21, 2026, 05:05 UTC · Open in terminal